Corcept Therapeutics reported $66.33M in Cash and Equivalent for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 114.85M 40M
Ani Pharmaceuticals ANIP:US USD 48.23M 8.05M
Ardelyx ARDX:US USD 84.31M 23.34M
Aurora Cannabis Inc ACB:CN CAD 258.71M 110.57M
Biomarin Pharmaceutical BMRN:US USD 724.53M 36.98M
Bristol Myers Squibb BMY:US USD 9.12B 1.39B
Canopy Growth Corp WEED:CN CAD 73.15M 245.28M
Corcept Therapeutics CORT:US USD 66.33M 16.09M
Depomed DEPO:US USD 64.94M 115K
Esperion Therapeutics ESPR:US USD 124.78M 34.62M
Knight Therapeutics Inc GUD:CN CAD 71.68M 67.41M
Lannett LCI:US USD 55.85M 22.07M
Lexicon Pharmaceuticals LXRX:US USD 46.34M 27.51M
Nektar Therapeutics NKTR:US USD 88.23M 17.53M
Novartis NOVN:VX USD 7.52B 1.21B
Novartis NVS:US USD 7.52B 1.21B
Omeros OMER:US USD 11.01M 134.52M
Pacira Pharmaceuticals PCRX:US USD 104.14M 5.28M
Supernus Pharmaceuticals SUPN:US USD 93.12M 18.37M
Tg Therapeutics TGTX:US USD 102.3M 7.56M
Ziopharm Oncology ZIOP:US USD 39.06M 1.25M